Current Neuropharmacology: review time and acceptance speed
ISSN 1570-159X · ISSN 1875-6190 · Bentham Science Publishers · Neuroscience
Half of the articles Current Neuropharmacology accepted in 2024 were accepted within 91 days of submission (n = 122); the middle half took 63–121 days.
Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026
How long does Current Neuropharmacology take to accept a paper?
| Year | Articles (n) | 25th pct | Median | 75th pct | 90th pct | Accepted <14 days | Have a revised date |
|---|---|---|---|---|---|---|---|
| 2024 | 122 | 63 | 91 | 121 | — | 1.6% | 84% |
| 2023 | 121 | 66 | 94 | 134 | — | 0.0% | 98% |
| 2022 | 196 | 77 | 107 | 148 | — | 0.0% | 99% |
| 2021 | 172 | 71 | 98 | 129 | — | 1.2% | 100% |
| 2020 | 130 | 57 | 86 | 107 | — | 0.0% | 100% |
- 2026: not shown yet — a year is reported once late-indexed articles have arrived (at least 247 days after it ends).
- 2025: not shown yet — a year is reported once late-indexed articles have arrived (at least 293 days after it ends).
Distribution in 2024
Show as a table
| Days | Articles | Share |
|---|---|---|
| 0–29 | 7 | 5.7% |
| 30–59 | 21 | 17.2% |
| 60–89 | 30 | 24.6% |
| 90–119 | 33 | 27.0% |
| 120–149 | 19 | 15.6% |
| 150–179 | 7 | 5.7% |
| 180–209 | 2 | 1.6% |
| 210–239 | 1 | 0.8% |
| 240–269 | 0 | 0.0% |
| 270–299 | 1 | 0.8% |
| 300–329 | 1 | 0.8% |
| 330–359 | 0 | 0.0% |
| 360+ | 0 | 0.0% |
From acceptance to online publication
Not enough articles with both an acceptance date and an online publication date to measure the time to online publication.
Read these numbers carefully
- These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
- Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
- Invited articles and special issues can move faster than regular submissions.
Open access status and publishing fees
Hybrid (subscription journal with an open-access option). No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.
OpenAPC has fewer than 5 reported payments for this journal in 2023–2025, so no typical amount is shown.
Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.
Integrity and indexing signals
Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.
| Listed in DOAJ | No |
|---|---|
| Articles indexed for MEDLINE in 2024 | Yes |
| Retractions | 0 retracted articles among 726 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database. |
| Accepted within 14 days of submission | 1.6% of 2024 articles |
| Publication volume | 87 articles added to PubMed in 2024 (-33% vs 2023). |
Topics and scope
- Neuroscience and Neuropharmacology Research (12% of indexed topics)
- Tryptophan and brain disorders (9% of indexed topics)
- Neurotransmitter Receptor Influence on Behavior (7% of indexed topics)
- Alzheimer's disease research and treatments (6% of indexed topics)
- Neuroinflammation and Neurodegeneration Mechanisms (6% of indexed topics)
- Cholinesterase and Neurodegenerative Diseases (5% of indexed topics)
Similar journals — faster or cheaper, side by side
Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2024 figures are compared with the 2024 median of Current Neuropharmacology, 91 days.
| Paid APC median | DOAJ | MEDLINE | |||
|---|---|---|---|---|---|
| CNS & Neurological Disorders - Drug Targets | 99 (2024, n = 69) | — | — | No | Yes |
| Neurochemistry International | 87 (2024, n = 173) | ≈$4,170 | — | No | Yes |
| Neurochemical Research | 104 (2024, n = 214) | ≈$4,590 | — | No | Yes |
| Pharmacological Reports | 89 (2024, n = 120) | ≈$3,290 | — | No | Yes |
| Cellular and Molecular Neurobiology | 109 (2024, n = 67) | ≈$4,590 | — | No | Yes |
| Neuropharmacology | 94 (2024, n = 266) | ≈$4,300 | — | No | Yes |
| Progress in Neuro-Psychopharmacology and Biological Psychiatry | 118 (2024, n = 271) | ≈$4,380 | — | No | Yes |
| Molecular Neurobiology | 158 (2024, n = 720) | ≈$4,590 | — | No | Yes |
| Molecular Brain | 81 (2024, n = 95) | $2,890 | $2,475 (8 payments) | Yes | Yes |
No journals match these filters.
Frequently asked questions
How long does Current Neuropharmacology take to accept a paper?
Half of the articles Current Neuropharmacology accepted in 2024 were accepted within 91 days of submission (n = 122); the middle half took 63–121 days. Based on dates in PubMed for accepted articles only.
Does Current Neuropharmacology charge an article processing charge (APC)?
No listed APC found in DOAJ or OpenAlex. That does not mean publishing is free — check the journal's author guidelines.
Sources and method
Journal identity: ISSN-L 1570-159X; NLM ID 101157239; OpenAlex record. Speed figures use 122 articles accepted in 2024 with valid dates; excluded records for that year: none.
Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.